Novo Nordisk has announced it is ending its distribution collaboration with US telehealth firm Hims & Hers Health over the ...

Key Takeaways U.S.-listed shares of Novo Nordisk fell more than 5% Monday after the Ozempic and Wegovy maker released results for its newest weight-loss treatment.In a pair of trials, patients lost an ...

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...